GlassScriptPhysician profile
Nancy H Broda
NPI 1265625545
$2,998.62
in general payments reported to CMS, 2019-2025
35 companies · $929 in 2025
The $929 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $502 · 2022: $341 · 2023: $409 · 2024: $817 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,155.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $442.30 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $324.47 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $263.24 | 2021-2025 | Ozempic, Rybelsus |
| Amgen INC. | $229.00 | 2021-2025 | Evenity, Repatha, Prolia |
| Phathom Pharmaceuticals, INC. | $194.93 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $183.67 | 2021-2025 | Xifaxan |
| Pfizer INC. | $165.54 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.44 | 2021-2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $116.35 | 2021-2025 | Trintellix |
| Corium, LLC | $97.31 | 2023-2024 | Azstarys, Adlarity |
| Abbvie INC. | $87.95 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $85.08 | 2023-2024 | Tryvio, Quviviq |
| Lundbeck LLC | $55.64 | 2023-2024 | Rexulti, Vyepti |
| Radius Health, INC. | $53.25 | 2025 | Tymlos |
| Abbott Laboratories | $52.11 | 2023-2024 | Freestyle Libre 3 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Broda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.